Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Journal of medical economics"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%229NDF7JZ4M3%22&type=Subject&filter%5B%5D=journalStr%3A%22Journal+of+medical+economics%22
/vufind/Search/Results?lookfor=%229NDF7JZ4M3%22&type=Subject&filter%5B%5D=journalStr%3A%22Journal+of+medical+economics%22
Search /vufind/Search2/Results?lookfor=%229NDF7JZ4M3%22&type=Subject&filter%5B%5D=journalStr%3A%22Journal+of+medical+economics%22
PubPharm (40)
1
Assessment of clinical and economic impact of rivaroxaban plus aspirin vs. aspirin alone as a secondary prophylaxis in patients with chronic and symptomatic peripheral arterial disease in the United States
enthalten in:
Journal of medical economics
| 2024
von
Shah, A.
|
Dabbous, F.
|
Shah, S.
| +2
Wird geladen...
2
Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain
enthalten in:
Journal of medical economics
| 2023
von
Muñoz, A.
|
Ortega, L.
|
Gutiérrez, A.
| +6
Wird geladen...
3
Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in Spain
enthalten in:
Journal of medical economics
| 2022
von
Muñoz, A.
|
Gallardo, E.
|
Agnelli, G.
| +5
Wird geladen...
4
Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation : results from a real-world cost-utility analysis
enthalten in:
Journal of medical economics
| 2022
von
Blomström Lundqvist, C.
|
Själander, S.
|
Garcia Rodriguez, L.
| +9
Wird geladen...
5
Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin
enthalten in:
Journal of medical economics
| 2021
von
Milentijevic, D.
|
Lin, J.
|
Chen, Y.
| +4
Wird geladen...
6
Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands
enthalten in:
Journal of medical economics
| 2021
von
Spoorendonk, J.
|
Briere, J.
|
Bowrin, K.
| +4
Wird geladen...
7
Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population
enthalten in:
Journal of medical economics
| 2021
von
Berger, J.
|
Laliberté, F.
|
Kharat, A.
| +5
Wird geladen...
8
Comparison of hospital length of stay of acute ischemic stroke patients with non-valvular atrial fibrillation started on rivaroxaban or warfarin treatment during hospitalization
enthalten in:
Journal of medical economics
| 2020
von
Yamashita, T.
|
Laurent, T.
|
Kato, M.
| +2
Wird geladen...
9
Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the US
enthalten in:
Journal of medical economics
| 2020
von
Milentijevic, D.
|
Germain, G.
|
Laliberté, F.
| +4
Wird geladen...
10
Cost-effectiveness of rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation in the Japanese healthcare setting
enthalten in:
Journal of medical economics
| 2020
von
Hori, M.
|
Tanahashi, N.
|
Akiyama, S.
| +3
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Journal of medical economics
Medienart
40
Aufsätze
40
E-Artikel
40
E-Ressourcen
Zeitschriftentitel
Journal of medical economics
Thema
40
9NDF7JZ4M3
40
Journal Article
40
Rivaroxaban
38
Anticoagulants
19
5Q7ZVV76EI
19
Warfarin
17
Dabigatran
17
I0VM4M70GC
16
Pyridones
16
Research Support, Non-U.S. Gov't
16
apixaban
15
3Z9Y7UWC1J
15
Pyrazoles
13
Morpholines
13
Thiophenes
11
rivaroxaban
9
I10
8
11P2JDE17B
8
Benzimidazoles
8
beta-Alanine
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
10
2020-
30
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
40
Englisch
Haven't found what you're looking for?
Wird geladen...